NEW YORK, NY / ACCESS Newswire / February 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West ...

The Friday morning market activity shows West Pharmaceutical Servs shares up by 2.21%, trading at $208.15. This implies a total value of $0 for Winters's 0 shares.

West Pharmaceutical Services Inc. closed 47.37% below its 52-week high of $400.88, which the company reached on March 21st.

We recently published a list of These Were Last Week’s 10 Worst Performers. In this article, we are going to take a look at ...

Currently, West Pharmaceutical Servs shares are trading up 2.21%, priced at $208.15 during Friday's morning. This values MacKay's 0 shares at $0.

CIBC Asset Management Inc raised its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 4.5% in the fourth quarter, HoldingsChannel reports. The firm owned 11,058 ...

West Pharmaceutical’s earnings results led to a 38% drop. Find out why WST stock could be worth watching for future rebounds ...

What Happened? Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) fell 34.9% in the afternoon ...

However, its future guidance fell short of market expectations, leading to a decline in its stock price after the announcement. Separately, with uncertainty surrounding the company, see What’s Next ...

West Pharmaceutical Services, Inc. (NYSE:WST) reported a fourth-quarter adjusted EPS of $1.82, beating the consensus of $1.72 ...

Headquartered in Exton, Pennsylvania, West in its fiscal year 2024 generated $2.89 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST ) and is included on the Standard & ...

Shares of West Pharmaceutical Services Inc. WST shed 4.03% to $202.49 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.24% ...